ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Early promise for new immunotherapy combo in brain cancer pharmatimes
April 13, 2021A combination treatment consisting of an experimental cancer drug – ipatasertib – and Roche’s immunotherapy agent Tecentriq (atezolizumab) has demonstrated early promise in an aggressive type of brain cancer.
Pharma Sources Insight January 2025
